Juni 2013 - Seite 2 von 2 - IOZK

Phase II study of dendritic cell vaccination combined with recombinant adenovirus-p53 in treatment for patients with advanced pancreatic carcinoma.

2013-06-03/in Dendritic Cells, Pancreatic Cancer /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3049)

Re-irradiation and hyperthermia after surgery for recurrent breast cancer

2013-06-03/in Breast Cancer, Hyperthermia, International Publications /von 2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-93

Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients

2013-06-02/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-06-02 / Cancer Immunol. Immunother. 2013 Aug;62(8):1381-92

Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: Results of phase I study.

2013-06-01/in Acute Leukemia, Dendritic Cells, International Publications /von 2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)